Perhaps it may just be what India — the diabetes capital of the world — needs, the Bengaluru-based Council for Scientific and Industrial Research (CSIR) has recently launched an Ayurvedic anti-diabetes pill called BGR-34, used for the management of type-2 diabetes (which is the most common one), which has been priced at Rs. 5.
According to A K S Rawat, Sr Principal Scientist of CSIR-NBRI, "We are sure that eminent medical professionals will recommend it to their patients suffering from type 2 Diabetes mellitus for quicker and consistent response". He further said that CSIR's premier research institutions have developed and established the efficacy of BGR-34, adding that the modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs.
The scientists of the other prestigious Indian scientific associations such as the National Botanical Research Institute (NBRI) and Central Institute of Medicinal and Aromatic Plants (CIMAP) joined hands in developing the drug and they had in-depth study of over 500 renowned ancient herbs and finally identified the six best herbs listed in the several Ayurvedic ancient texts to develop an anti-diabetic formulation.
The scientists are hopeful of a positive response from medical professionals and patients. According to Daya Nandan Mani, Senior Scientist of CSIR-NBRI, the Pre-clinical studies of this anti-diabetic formulation revealed significant reduction in high blood sugar level in diabetes induced experimental subjects.
India had over 6.5 crore diabetic patients and nearly 3 percent of deaths occurring annually in the country are due to diabetes. No wonder, India is regarded as the diabetes capital of the world.